Within the context of a continuing broad interest in various factors influencing leukocyte proliferation and differentiation, specific studies will attempt to: (1) continue to explore mechanisms involved in the regulation of human lymphocyte proliferation in short-term cultures; and (2) further delineate the role of cytogenetic abnormalities (both the specific chromosomes involved and the types of aberrations) in the initiation and subsequent evolution of human preleukemic disorders and atypical acute leukemia. For the studies of normal lymphocytes, we will emphasize the role of soluble growth factors (interleukins) in both mitogen-stimulated and antigen-stimulated cultures, and particularly stimulatory and inhibitory factors influencing T-cell proliferation. These investigations will utilize cultures of normal human lymphocytes exposed to various factors in combination with different mitogens and antigens, and are now being extended to include effects on expression of cell-cycle specific genes. For the chromosome studies, we will extend and broaden an existing long-term study of preleukemic disorders and the prognostic and biologic significance of specific cytogenetic disorders. These investigations will not only have clinical applications but will also extend our understanding of the significance of genetic alterations in the initiation and evolution of human neoplastic cell populations. In a related study, we will explore familial patterns of atypical chromosomal fragility and its relationship to the risk of preleukemia and leukemia. (HF)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA012779-13S1
Application #
3163679
Study Section
Pathology B Study Section (PTHB)
Project Start
1977-09-01
Project End
1986-04-30
Budget Start
1985-03-01
Budget End
1986-04-30
Support Year
13
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Spinner, N B; Emanuel, B S; Vonderheid, E C et al. (1987) Chronic myelomonocytic leukemia in a patient with a familial t(6;16)(q13;q22) translocation. Cancer Genet Cytogenet 29:159-64
Reed, J C; Alpers, J D; Scherle, P A et al. (1987) Proto-oncogene expression in cloned T lymphocytes: mitogens and growth factors induce different patterns of expression. Oncogene 1:223-8
Reed, J C; Prystowsky, M B; Kern, J A et al. (1987) Regulation of proto-oncogene expression during T lymphocyte activation and proliferation. Adv Exp Med Biol 213:249-62
Taylor, D S; Nowell, P C; Kornbluth, J (1987) Anti-HLA class I antibodies inhibit the T cell-independent proliferation of human B lymphocytes. J Immunol 139:1792-6
Huebner, K; Isobe, M; Chao, M et al. (1986) The nerve growth factor receptor gene is at human chromosome region 17q12-17q22, distal to the chromosome 17 breakpoint in acute leukemias. Proc Natl Acad Sci U S A 83:1403-7
Conley, M E; Spinner, N B; Emanuel, B S et al. (1986) A chromosomal breakage syndrome with profound immunodeficiency. Blood 67:1251-6
Reed, J C; Jegasothy, B V; Batra, B K et al. (1986) The lymphokine ""inhibitor of DNA synthesis"" (IDS) suppresses human T lymphocyte proliferation by an interleukin-2-independent mechanism. Lymphokine Res 5:11-20
Hoxie, J A; Alpers, J D; Rackowski, J L et al. (1986) Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. Science 234:1123-7
Abrahm, J; Besa, E C; Hyzinski, M et al. (1986) Disappearance of cytogenetic abnormalities and clinical remission during therapy with 13-cis-retinoic acid in a patient with myelodysplastic syndrome: inhibition of growth of the patient's malignant monocytoid clone. Blood 67:1323-7
Nowell, P C; Besa, E C; Stelmach, T et al. (1986) Chromosome studies in preleukemic states. V. Prognostic significance of single versus multiple abnormalities. Cancer 58:2571-5

Showing the most recent 10 out of 22 publications